DESMOPRESSINE ZENTIVA 60 micrograms, sublingual tablet 100 tablets
Active ingredients: Desmopressin acetate, Desmopressin
Commercialized according to BDPMDispensing in France: Prescription only
Tablet100 tabletssublinguale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DESMOPRESSINE ZENTIVA 60 microgrammes, comprimé sublingual
- Pharmaceutical form
- comprimé
- Route of administration
- sublinguale
- Presentation description
- plaquettes OPA : polyamide orienté aluminium PVC polyéthylène de 100 comprimés
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Mar 2024
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68826207CIP73027707CIP133400930277072Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DESMOPRESSINEcomprimé | 60 microgrammes · un comprimé | FT |
| ACÉTATE DE DESMOPRESSINEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.